U.S. Vaccine Deal With Pfizer at $20 a Dose Sets Bar for Rivals

(Bloomberg) -- In signing a $2 billion deal to supply their experimental coronavirus vaccine to the U.S., Pfizer Inc. and BioNTech SE are setting a price ceiling of less than $20 a dose that will i...